FDA misses deadline for decision on Novavax’s COVID-19 vaccine, WSJ reports
By Thomson ReutersApr 2, 2025 | 11:29 AM
(Reuters) -The U.S. Food and Drug Administration have missed the deadline for making a key decision on Novavax’s COVID-19 vaccine, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Shreya Biswas)
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.
